For this reason, engineered mouse models harboring mutation in genes, such as SDH, IDH, and FH have been proposed for the systemic and dynamic analysis of tumor syndromes dependent on metabolism abnormalities (*mice with tumor cells or tissue xenografts recapitulate part of the disadvantages presented for each biological samples). This evidence concerns the gene FH and neoplasm.